Lercanidipine Impurity 4, identified by its CAS number 2727061-30-3, is a chemical compound associated with the pharmaceutical agent lercanidipine, which is primarily used as an antihypertensive medication. As an impurity, it may arise during the synthesis or degradation of lercanidipine and is typically characterized by its specific molecular structure and properties. Impurities like Lercanidipine Impurity 4 are often evaluated for their potential impact on the efficacy and safety of the primary drug. The characteristics of such impurities can include aspects like solubility, stability, and reactivity, which are crucial for understanding their behavior in pharmaceutical formulations. Analytical techniques such as chromatography and mass spectrometry are commonly employed to identify and quantify impurities in drug substances. Regulatory guidelines often dictate the acceptable levels of impurities in pharmaceutical products to ensure patient safety and drug quality. Understanding the characteristics of impurities is essential for pharmaceutical development and quality control processes.

Lercanidipine Impurity 4

2727061-30-3: Lercanidipine Impurity 4, identified by its CAS number 2727061-30-3, is a chemical compound associated with the pharmaceutical agent lercanidipine, which is primarily used as an antihypertensive medication. As an impurity, it may arise during the synthesis or degradation of lercanidipine and is typically characterized by its specific molecular structure and properties. Impurities like Lercanidipine Impurity 4 are often evaluated for their potential impact on the efficacy and safety of the primary drug. The characteristics of such impurities can include aspects like solubility, stability, and reactivity, which are crucial for understanding their behavior in pharmaceutical formulations. Analytical techniques such as chromatography and mass spectrometry are commonly employed to identify and quantify impurities in drug substances. Regulatory guidelines often dictate the acceptable levels of impurities in pharmaceutical products to ensure patient safety and drug quality. Understanding the characteristics of impurities is essential for pharmaceutical development and quality control processes.

CAS 2727061-30-3

Lercanidipine Impurity 4

N-Methyl-3,3-diphenylpropanamine Acetate

Ref: 86-MM3441.04

N-Methyl-3,3-diphenylpropylamine Acetate Salt

Ref: 4Z-P-2651